Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Bromfenac/difluprednate

Lack of efficacy and rebound effect in the form of reopened macular hole

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ali AA, et al. Macular Hole Closure With Intravitreal Dexamethasone Implant. Ophthalmic Surgery, Lasers & Imaging Retina 54 : 548-549, No. 9, Sep 2023. Available from: URL: https://dx.doi.org/10.3928/23258160-20230809-02 Ali AA, et al. Macular Hole Closure With Intravitreal Dexamethasone Implant. Ophthalmic Surgery, Lasers & Imaging Retina 54 : 548-549, No. 9, Sep 2023. Available from: URL: https://dx.doi.org/10.3928/23258160-20230809-02
Metadaten
Titel
Bromfenac/difluprednate
Lack of efficacy and rebound effect in the form of reopened macular hole
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54403-6

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Heparin

Case report

Multiple drugs

Case report

Prednisone

Case report

Tildrakizumab